Daily feed · SEC Form 4 filings
Significant insider purchases — Jan 24, 2019
Open-market purchases of at least $50,000 — or at least $500,000 when the buyer is a 10% owner.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2019 PForm 4 → | Jan 23, 4:23 pm EST | Kindred Biosciences, Inc.KIN | Park West Asset Management LLC10% Owner | 741,840 | $9.50 | $7,047,480 | 6,743,893 | +12.4% | plan? |
| Jan 22, 2019 PForm 4 → | Jan 24, 2:46 pm EST | Neuberger Berman High Yield Strategies Fund Inc.NHS | Saba Capital Management, L.P. +110% Owner | 204,332 | $10.39 | $2,122,490 | 2,183,420 | +10.3% | plan? |
| Jan 18, 2019 PForm 4 → | Jan 23, 5:58 pm EST | ALPINE IMMUNE SCIENCES, INC.ALPN | ORBIMED ADVISORS LLC +1Director, 10% Owner | 372,439 | $5.37 | $1,999,997 | 3,670,955 | +11.3% | plan? |
| Jan 18, 2019 PForm 4 → | Jan 23, 6:01 pm EST | ALPINE IMMUNE SCIENCES, INC.ALPN | Peter A. ThompsonDirector, 10% Owner | 372,439 | $5.37 | $1,999,997 | 3,670,955 | +11.3% | plan? |
| Jan 22, 2019 PForm 4 → | Jan 23, 6:21 pm EST | FS KKR Capital CorpFSK | Michael C. FormanChief Executive Officer, Director | 40,854 | $6.08 | $248,292 | 66,234 | +161% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.